Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Richard Socher's new $650 million startup wants to build an AI that can research and improve itself indefinitely — and he ...

JEP 533, Structured Concurrency, has reached integrated status for JDK 27. It refines exception handling and type safety in ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...